@shareepage1's peptide therapy claims need context

What did @shareepage1 actually say?

The creator dislocated their shoulder at the gym and immediately announced they would use BPC-157 daily, injected into the shoulder, to speed recovery. The framing is a self-experiment: they want to know if healing happens faster than previous dislocations that took "weeks and weeks and weeks." They explicitly invoked the term "Wolverine peptide," which is a popular social media shorthand for BPC-157's supposed rapid regenerative properties. No dose, no protocol, no physician is mentioned. Just the injury, the peptide, and a promise to report back.

To the creator's credit, they do acknowledge the injury is serious and that you "should let the tendons and stuff around the socket heal." That's not nothing. They're not telling you to push through the pain and train anyway. But by framing this as a test of a specific marketing claim, they're setting up an n=1 anecdote as if it could actually answer the question.

Does the science back this up?

The honest answer is: maybe, but we genuinely don't know yet, and the evidence base is much thinner than BPC-157's reputation suggests. Most of the compelling data comes from animal studies, not human trials. A 2024 review by Chang et al. in Biomedicine and Pharmacotherapy summarized that BPC-157 shows consistent pro-healing effects in rodent models of tendon, ligament, and muscle injury, but noted the near-total absence of randomized controlled trials in humans.

The peptide appears to upregulate growth hormone receptor expression and promote angiogenesis at injury sites, which theoretically supports connective tissue repair. Studies by Seiwerth et al. (multiple publications in Current Pharmaceutical Design) show accelerated tendon-to-bone healing in rat models specifically relevant to shoulder-type injuries. But rats healing faster is not the same as humans healing faster. The jump from animal model to clinical reality is where BPC-157 hype consistently outruns the data.

What did they get wrong (or right)?

They got the injury seriousness right. A shoulder dislocation stretches or tears the capsule, labrum, and surrounding ligaments. Recovery timelines of several weeks are accurate and not dramatic. Giving credit where it's due: the creator isn't minimizing the injury or encouraging unsafe behavior.

What they got wrong is the implicit suggestion that "Wolverine peptide" is an established descriptor backed by evidence. It's not. It's a gym-culture nickname. The claim that BPC-157 accelerates healing in this context is plausible based on mechanism, but unproven in humans for acute shoulder joint injuries specifically. An n=1 comparison to previous dislocations from years ago, before shoulder surgery, is also deeply flawed methodology. Their shoulder anatomy is different now. Their age may differ. Prior surgery changes the structural landscape entirely, making any comparison to pre-surgical dislocations essentially meaningless as evidence.

They also don't mention that local injection into a recently dislocated shoulder carries real risks and should not be self-administered without medical supervision.

What should you actually know?

BPC-157 is not FDA-approved. It is a research compound. As of 2023, the FDA took action to restrict compounded BPC-157, citing insufficient evidence of clinical benefit and safety concerns. That matters if you're thinking about sourcing or using it.

The mechanism behind BPC-157's proposed benefits is biologically plausible. It's a partial sequence of a protein found in gastric juice. Research by Gwyer et al. (2019, Current Opinion in Pharmacology) confirmed it interacts with the nitric oxide system and growth factor signaling pathways in ways that could support tissue repair. But plausible mechanism is not the same as proven clinical outcome.

If you have a dislocated shoulder, the evidence-backed interventions are reduction by a trained clinician, appropriate immobilization, physical therapy, and in some cases surgery. None of those are replaced by any peptide. Anyone injecting an unregulated compound into a freshly injured joint without medical oversight is taking on significant, poorly quantified risk.

The bottom line on this video

This video is a well-meaning anecdote in progress. The creator is curious, not reckless, and they're honest that they "pray" it works, which at least signals uncertainty. But the framing, testing whether BPC-157 "truly is the Wolverine peptide it claims to be," presents a marketing claim as if it's a testable hypothesis. One person's shoulder recovery, compared to surgically altered anatomy from years prior, cannot answer that question. Watch the follow-up if it comes, but don't treat it as evidence either way.